Observational studyThoracic cancer2026

Prospective Multicenter Observational Study of Anlotinib in Advanced Non-Small Cell Lung Cancer: Real-World Evidence From China.

Jinlin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.